Astrana Health (ASTH) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $36.81, -3.21% vs the prior close of $38.03.
- Volume 239.99K shares, 0.6x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
ASTH slides 3.2% to $36.81. Closed at $36.81, -3.21% vs the prior close of $38.03. Day range $36.53–$38.17, opened at $38.03.
ASTH daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — ASTH slides 3.2% to $36.81
- Closed at $36.81, -3.21% vs the prior close of $38.03. Day range $36.53–$38.17, opened at $38.03.
- Volume was 239.99K shares, 0.6x its 50-day average of 412.12K — lighter than usual.
- Price is -1.1% vs its 50-day average ($37.22) and +10.4% vs its 200-day average ($33.34).
- 52-week range $18.08–$51.60; today's close sits at 56% of that range, 28.7% below the 52-week high.
Oct 15, 2026 — ASTH rises 0.8% to $38.03
- Closed at $38.03, +0.82% vs the prior close of $37.72. Day range $37.63–$39.01, opened at $38.01.
- Volume was 260.50K shares, 0.6x its 50-day average of 417.16K.
- Price is +2.3% vs its 50-day average ($37.17) and +14.3% vs its 200-day average ($33.28).
- 52-week range $18.08–$51.60; today's close sits at 60% of that range, 26.3% below the 52-week high.
Oct 14, 2026 — ASTH dips 0.4% to $37.72
- Closed at $37.72, -0.40% vs the prior close of $37.87. Day range $36.93–$38.58, opened at $37.32.
- Volume was 446.10K shares, 1.1x its 50-day average of 416.24K.
- Price is +1.6% vs its 50-day average ($37.13) and +13.6% vs its 200-day average ($33.22).
- 52-week range $18.08–$51.60; today's close sits at 59% of that range, 26.9% below the 52-week high.
Oct 13, 2026 — ASTH dips 1.4% to $37.87
- Closed at $37.87, -1.38% vs the prior close of $38.40. Day range $37.42–$39.87, opened at $38.98.
- Volume was 268.20K shares, 0.6x its 50-day average of 421.42K.
- Price is +2.1% vs its 50-day average ($37.09) and +14.2% vs its 200-day average ($33.15).
- 52-week range $18.08–$51.60; today's close sits at 59% of that range, 26.6% below the 52-week high.
Oct 12, 2026 — ASTH rises 2.3% to $38.40
- Closed at $38.40, +2.26% vs the prior close of $37.55. Day range $36.06–$38.55, opened at $37.72.
- Volume was 294.50K shares, 0.7x its 50-day average of 428.17K.
- Price is +3.7% vs its 50-day average ($37.05) and +16.0% vs its 200-day average ($33.09).
- 52-week range $18.08–$51.60; today's close sits at 61% of that range, 25.6% below the 52-week high.
Oct 9, 2026 — ASTH jumps 4.7% to $37.55
- Closed at $37.55, +4.68% vs the prior close of $35.87. Day range $35.87–$37.70, opened at $35.87.
- Volume was 314.90K shares, 0.7x its 50-day average of 430.71K.
- Price is +1.5% vs its 50-day average ($36.99) and +13.7% vs its 200-day average ($33.02).
- 52-week range $18.08–$51.60; today's close sits at 58% of that range, 27.2% below the 52-week high.
Oct 8, 2026 — ASTH slides 3.4% to $35.87
- Closed at $35.87, -3.42% vs the prior close of $37.14. Day range $35.38–$36.96, opened at $36.81.
- Volume was 351.10K shares, 0.8x its 50-day average of 433.70K.
- Price is -3.0% vs its 50-day average ($36.97) and +8.9% vs its 200-day average ($32.95).
- 52-week range $18.08–$51.60; today's close sits at 53% of that range, 30.5% below the 52-week high.
Oct 7, 2026 — ASTH rises 0.4% to $37.14, 4 up days in a row
- Closed at $37.14, +0.38% vs the prior close of $37.00. Day range $36.65–$37.66, opened at $36.65.
- Volume was 664.50K shares, 1.5x its 50-day average of 433.35K.
- Price is +0.4% vs its 50-day average ($36.99) and +12.9% vs its 200-day average ($32.89).
- 52-week range $18.08–$51.60; today's close sits at 57% of that range, 28.0% below the 52-week high.
- That makes 4 straight gains.
Oct 6, 2026 — ASTH rises 0.5% to $37.00, 3 up days in a row
- Closed at $37.00, +0.52% vs the prior close of $36.81. Day range $36.78–$37.70, opened at $37.12.
- Volume was 227.10K shares, 0.5x its 50-day average of 440.78K — lighter than usual.
- Price is -0.0% vs its 50-day average ($37.00) and +12.7% vs its 200-day average ($32.82).
- 52-week range $18.08–$51.60; today's close sits at 56% of that range, 28.3% below the 52-week high.
- That makes 3 straight gains.
Oct 5, 2026 — ASTH rises 2.6% to $36.81
- Closed at $36.81, +2.59% vs the prior close of $35.88. Day range $35.73–$37.06, opened at $35.73.
- Volume was 389.90K shares, 0.9x its 50-day average of 441.82K.
- Price is -0.6% vs its 50-day average ($37.03) and +12.4% vs its 200-day average ($32.75).
- 52-week range $18.08–$51.60; today's close sits at 56% of that range, 28.7% below the 52-week high.
Oct 2, 2026 — ASTH rises 2.8% to $35.88
- Closed at $35.88, +2.78% vs the prior close of $34.91. Day range $35.11–$36.39, opened at $35.53.
- Volume was 310.40K shares, 0.7x its 50-day average of 453.05K.
- Price is -3.3% vs its 50-day average ($37.10) and +9.8% vs its 200-day average ($32.68).
- 52-week range $18.08–$51.60; today's close sits at 53% of that range, 30.5% below the 52-week high.
ASTH latest news & SEC filings
Every SEC filing by or about ASTH in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 13, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Vong John had withheld for taxes 556 shares at $37.55 (≈$20.88K) on Oct 10, 2026; now holds 21,774
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 8, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Sim Brandon had withheld for taxes 9,889 shares at $37.00 (≈$365.89K) on Oct 6, 2026; now holds 1,228,972
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 8, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Lam Thomas S. had withheld for taxes 2,624 shares at $37.00 (≈$97.09K) on Oct 6, 2026; now holds 463,033
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 6, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Basho Chandan had withheld for taxes 2,092 shares at $35.88 (≈$75.06K) on Oct 2, 2026; now holds 155,728
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 23, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 23, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.05 — Material cybersecurity incident.
Sep 17, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Vong John had withheld for taxes 96 shares at $38.35 (≈$3.68K) on Sep 15, 2026; now holds 22,330
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 15, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 9, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 10, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $972.52M (prior year $654.81M) (+48.5% vs Jun 30, 2025)
- Net income: $19.74M (prior year $9.42M) (+109.5% vs Jun 30, 2025)
- Diluted EPS: $0.40 (prior year $0.19) (+110.5% vs Jun 30, 2025)
Aug 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 31, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Jul 1, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Things to know before you trade ASTH
- Last results release: Aug 6, 2026 (8-K Item 2.02). Previous ones: May 7, 2026, Mar 2, 2026, Nov 6, 2025. Based on that rhythm, the next report is likely around Nov 5, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.20% (largest 5.6%).
- Liquidity: about 360.35K shares (≈$13.26M) trade per day on average.
- 52-week position: $36.81 vs a range of $18.08–$51.60 (56% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Sep 23, 2026; 8-K Sep 23, 2026; 8-K Sep 15, 2026.
- Share count: 55.74M shares outstanding (Aug 3, 2026), -0.6% vs a year earlier.
- Listing: Nasdaq · industry: Services-Management Consulting Services.
ASTH market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 38.03 | 38.17 | 36.53 | 36.81 | 239.99K |
| Oct 15, 2026 | 38.01 | 39.01 | 37.63 | 38.03 | 260.50K |
| Oct 14, 2026 | 37.32 | 38.58 | 36.93 | 37.72 | 446.10K |
| Oct 13, 2026 | 38.98 | 39.87 | 37.42 | 37.87 | 268.20K |
| Oct 12, 2026 | 37.72 | 38.55 | 36.06 | 38.40 | 294.50K |
| Oct 9, 2026 | 35.87 | 37.70 | 35.87 | 37.55 | 314.90K |
| Oct 8, 2026 | 36.81 | 36.96 | 35.38 | 35.87 | 351.10K |
| Oct 7, 2026 | 36.65 | 37.66 | 36.65 | 37.14 | 664.50K |
| Oct 6, 2026 | 37.12 | 37.70 | 36.78 | 37.00 | 227.10K |
| Oct 5, 2026 | 35.73 | 37.06 | 35.73 | 36.81 | 389.90K |
| Oct 2, 2026 | 35.53 | 36.39 | 35.11 | 35.88 | 310.40K |
| Oct 1, 2026 | 35.61 | 35.68 | 34.71 | 34.91 | 266.80K |
| Sep 30, 2026 | 35.49 | 35.97 | 34.81 | 35.57 | 398.90K |
| Sep 29, 2026 | 35.09 | 35.66 | 34.46 | 35.45 | 264.30K |
| Sep 28, 2026 | 36.29 | 36.83 | 34.74 | 35.13 | 363.60K |
| Sep 25, 2026 | 34.46 | 36.41 | 34.11 | 36.37 | 336.60K |
| Sep 24, 2026 | 34.32 | 34.54 | 33.54 | 34.44 | 391.50K |
| Sep 23, 2026 | 33.08 | 34.46 | 32.22 | 34.34 | 405.10K |
| Sep 22, 2026 | 34.11 | 35.52 | 33.40 | 35.11 | 409.50K |
| Sep 21, 2026 | 34.40 | 34.44 | 32.22 | 33.55 | 603.50K |
About Astrana Health
Astrana Health (ASTH) is listed on the Nasdaq and classified by the SEC under “Services-Management Consulting Services”. Its business address is in ALHAMBRA, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1083446.
ASTH board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| John Chiang | Director | Jun 12, 2026 |
| Weili Dai, | Director | Jun 12, 2026 |
| Linda Dong | Director | Jun 12, 2026 |
| Mitchell W Kitayama | Director | Sep 1, 2026 |
| Thomas S. Lam | Director | Apr 8, 2026 |
| Linda Marsh | Director | Nov 5, 2025 |
| Matthew Mazdyasni | Director | Jun 12, 2026 |
| David Schmidt | Director | Aug 18, 2026 |
| Kenneth T. Sim | Executive Chairman | Apr 8, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Chandan Basho | COO and CFO | Sep 8, 2026 |
| Dinesh M. Kumar | Chief Medical Officer | Apr 3, 2026 |
| Brandon Sim | CEO and President | Sep 9, 2026 |
| Kenneth T. Sim | Executive Chairman | Apr 8, 2026 |
| John Vong | SVP - Accounting (PAO) | Sep 17, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
ASTH financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $3.18B | $22.49M | 0.46 | $114.60M |
| Dec 31, 2024 | $2.03B | $43.15M | 0.90 | $52.20M |
| Dec 31, 2023 | $1.39B | $60.72M | 1.29 | $68.23M |
| Dec 31, 2022 | $1.14B | $45.17M | 0.99 | $82.13M |
| Dec 31, 2021 | $773.91M | $68.92M | 1.52 | $70.33M |
Latest balance sheet: total assets $2.28B, total liabilities $1.68B, cash $400.79M (as of Jun 30, 2026).
ASTH earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 6, 2026 | 8-K Item 2.02 (results) | $34.13 |
| May 7, 2026 | 8-K Item 2.02 (results) | $36.08 |
| Mar 2, 2026 | 8-K Item 2.02 (results) | $26.32 |
| Nov 6, 2025 | 8-K Item 2.02 (results) | $33.36 |
| Aug 7, 2025 | 8-K Item 2.02 (results) | $21.46 |
| Jul 2, 2025 | 8-K Item 2.02 (results) | $24.65 |
| May 8, 2025 | 8-K Item 2.02 (results) | $33.44 |
| Feb 27, 2025 | 8-K Item 2.02 (results) | $34.68 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $59.08 |
| Aug 7, 2024 | 8-K Item 2.02 (results) | — |
| May 7, 2024 | 8-K Item 2.02 (results) | — |
| Feb 27, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Services-Management Consulting Services
Booz Allen Hamilton (BAH)Fti Consulting (FCN)Genpact (G)Huron Consulting (HURN)Exponent (EXPO)Cgi (GIB)Bowman Consulting (BWMN)ICF International (ICFI)Onterris (ONT)Tss (TSSI)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on ASTH
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.